Compagno et al. reported that somatic mutation of TRAF5 sustained the activity of NF-kB signaling, which was associated with most aggressive subtype, activated B-cell-like Diffuse large B-cell lymphoma [41]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.